OPCH Stock Analysis: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$21.97
0.67 (3.15%)
▲
5d:
+3.49%
30d:
+2.09%
90d:
-22.67%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OPCH shows positive signals but monitor for confirmation. Market pricing in 9.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: OPCH shows positive signals but monitor for confirmation. Market pricing in 9.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$42.61
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$26.46
17.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $21.97, which is considered extended relative to its 30-day fair value range of $20.32 to $21.70. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.7) compared to its historical average (14.4). Remarkably, the market is currently pricing in an annual earnings decline of 9.4% over the next few years. This pessimistic expectation contrasts with the company's recent 3.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is in a strong downtrend. The price is approaching resistance at $21.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: OPCH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.58 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OPCH is in a strong downtrend. The price is approaching resistance at $21.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: OPCH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.58 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.32 -
$21.70
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 30.1% below Wall St target ($28.58)
Trading Range Analysis
30-Day Trading Range
$20.32 -
$21.70
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.87
Resistance Level
$21.80
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.72
Wall Street Target
$28.58
(+30.1%)
Revenue Growth (YoY)
1.3%
Earnings Growth (YoY)
3.4%
Profit Margin
3.6%
Valuation Discount vs History
-9.4% cheaper
PE vs Historical
10.7 vs 14.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.4%
(market-implied from PE analysis)
1-Year Target
$19.90
(-9%)
2-Year Target
$18.03
(-18%)
3-Year Target
$16.34
(-26%)
3-Yr Target (if PE normalizes)
(PE: 11→14)
$21.95
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.3%)
$61.57
(+180%)
Base:
(SPY PE: 10.7, Growth: 11.3%)
$30.30
(+38%)
Bear:
(PE: 9.1, Growth: 11.3%)
$25.76
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 16.64 | Current EPS (TTM): $1.28
Bull Case
$37.52
(+71%)
Analyst growth 60.1%, PE expands to 18.3
Base Case
$34.11
(+55%)
Market implied 60.1%, PE stable at 16.6
Bear Case
$14.48
(-34%)
Severe decline -20.0%, PE contracts to 14.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.7 to 14.4
Stabilization Target:
$29.51
(+34.3%)
PE Expansion Potential:
+34.3%
Share & Embed Analysis
Last updated: June 23, 2026 6:05 PM ET
Data refreshes hourly during market hours. Next update: 7:05 PM
Data refreshes hourly during market hours. Next update: 7:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
